Recruiting
Phase 3

Dapsone Coronavirus SARS-CoV-2 Trial (DAP-CORONA) COVID-19

Sponsor:

McGill University Health Centre/Research Institute of the McGill University Health Centre

Code:

NCT04935476

Conditions

COVID-19

Eligibility Criteria

Sex: All

Age: 40+

Healthy Volunteers: Not accepted

Interventions

Dapsone 85 mg PO BID

Placebo 85 mg PO BID

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information